Physician

Robert F. Sprung, M.D.

According to 2025 Medicare claims, Robert Sprung, M.D. (NPI: 1255314837) practices cardiology in the Farmington, NM market, with the plurality of this provider's patient population coming from San Juan, NM. This provider's primary affiliated billing organization is FOUR CORNERS HEART AND LUNG INSTITUTE PC (NPI: 1477859122; TIN: 274595817) and primary practice location at 87401-4570.

Sprung's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 263 traditional Medicare patients, billed 2,525 HCPCS/CPT codes, and received $137,384 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 6,251 prescription claims across 390 beneficiaries totaling $1,198,917 in drug costs, led by Repatha Sureclick (Evolocumab). DME data shows 1,754 claims. Open Payments data shows 8 records totaling $279. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $308,213 to $1,198,917. For DME billing, reported payments rose steadily, from $100,370 to $156,600.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	352	3,293	$204,313
2016	354	3,452	$200,807
2017	324	3,433	$185,459
2018	322	2,845	$155,740
2019	362	2,535	$145,969
2020	326	2,856	$133,421
2021	326	2,677	$165,734
2022	292	2,803	$155,522
2023	268	2,681	$155,150
2024	263	2,525	$137,384

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	302	3,431	$308,213
2016	311	3,553	$426,937
2017	317	3,873	$527,953
2018	343	4,446	$638,527
2019	352	5,004	$622,344
2020	355	5,519	$714,665
2021	380	5,511	$793,085
2022	388	6,020	$1,056,260
2023	378	6,226	$1,342,387
2024	390	6,251	$1,198,917

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	326	1,271	$108,237
2016	385	1,754	$105,631
2017	358	1,798	$138,178
2018	389	1,622	$142,258
2019	366	1,438	$142,713
2020	411	1,727	$197,534
2021	335	1,595	$192,943
2022	267	1,575	$171,702
2023	289	1,881	$202,847
2024	334	1,754	$177,174

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	246	734	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	101	152	$69
99211	Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional	217	533	$15
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	112	187	$10
36415	Insertion of needle into vein for collection of blood sample	198	490	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Repatha Sureclick	Evolocumab	112	6,308	$119,436
Eliquis	Apixaban	90	5,970	$114,161
Ozempic	Semaglutide	74	3,137	$102,091
Xarelto	Rivaroxaban	70	3,895	$72,311
Jardiance	Empagliflozin	48	3,870	$69,408

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	127	972	$76,983
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	58	$59,269
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	22	81	$11,778
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	13	$9,715
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	22	74	$4,761

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$279	Mylan Specialty L.P.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert F. Sprung, M.D.?

Tedicare shows public-source Medicare data for Robert F. Sprung, M.D. (NPI 1255314837), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert F. Sprung, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert F. Sprung, M.D.?

Robert F. Sprung, M.D. is linked to FOUR CORNERS HEART AND LUNG INSTITUTE PC (billing NPI 1477859122) in the available physician profile data.

Does Robert F. Sprung, M.D. have Open Payments data?

Robert F. Sprung, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.